Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kastenmayer James Paul | General Counsel | 2 | $0 | $0 | 2021-03-15 |
| Chan Mitchell | Chief Financial Officer | 6 | $0 | $0 | 2021-03-15 |
| Drappa Jorn | Chief Medical Officer | 5 | $0 | $0 | 2021-03-15 |
| Ragatz William | VP, Head of Commercial | 7 | $0 | $0 | 2021-03-15 |
| Nolet Chris | Director | 4 | $0 | $0 | 2021-03-15 |
| Jacques Rachelle Suzanne | Director | 5 | $0 | $0 | 2021-03-15 |
| AstraZeneca UK LTD | 10% Owner | 1 | $0 | $0 | 2021-03-15 |
| Yao Zhengbin | Chief Executive Officer | 6 | $0 | $0 | 2021-03-15 |
| Hu Edward | Director | 16 | $0 | $7.95M | 2021-03-15 |
| Cao Yanling | Director, 10% Owner | 10 | $0 | $16.92M | 2021-03-13 |
| Boyu Capital Fund III, L.P. | 10% Owner | 2 | $0 | $0 | 2021-03-13 |
| Wicki Andreas | Director | 4 | $9.50M | $0 | 2021-03-13 |
| Ren Aaron | VP, Head of Bus. Dev & Oper. | 3 | $0 | $0 | 2020-11-18 |
| Tong Xiaomeng | Director, 10% Owner | 16 | $12.98M | $35.44M | 2020-06-05 |
| Boyu Capital Investment Management Ltd | 10% Owner | 7 | $6.49M | $800.5K | 2019-10-08 |
| ASTRAZENECA PLC | 10% Owner | 3 | $8.07M | $0 | 2019-10-07 |
| Boundless Meadow Ltd | 10% Owner | 4 | $0 | $0 | 2019-10-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Yao Zhengbin | Chief Executive Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 309,375 | — | $0 | 0 | SEC↗ |
| Yao Zhengbin | Chief Executive Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 188,057 | — | $0 | 0 | SEC↗ |
| Yao Zhengbin | Chief Executive Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 120,000 | — | $0 | 0 | SEC↗ |
| Ragatz William | Senior VP, Head of Commercia | D To issuer deriv | 2021-03-15 | 2021-03-15 | 13,000 | — | $0 | 0 | SEC↗ |
| Ragatz William | Senior VP, Head of Commercia | D To issuer deriv | 2021-03-15 | 2021-03-15 | 50,548 | — | $0 | 0 | SEC↗ |
| Ragatz William | Senior VP, Head of Commercia | D To issuer deriv | 2021-03-15 | 2021-03-15 | 48,750 | — | $0 | 0 | SEC↗ |
| Jacques Rachelle Suzanne | Director | D To issuer deriv | 2021-03-15 | 2021-03-15 | 7,358 | — | $0 | 0 | SEC↗ |
| Jacques Rachelle Suzanne | Director | D To issuer deriv | 2021-03-15 | 2021-03-15 | 14,716 | — | $0 | 0 | SEC↗ |
| Nolet Chris | Director | D To issuer deriv | 2021-03-15 | 2021-03-15 | 7,358 | — | $0 | 0 | SEC↗ |
| Nolet Chris | Director | D To issuer deriv | 2021-03-15 | 2021-03-15 | 26,210 | — | $0 | 0 | SEC↗ |
| Kastenmayer James Paul | General Counsel | D To issuer deriv | 2021-03-15 | 2021-03-15 | 50,000 | — | $0 | 0 | SEC↗ |
| Drappa Jorn | Chief Medical Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 71,842 | — | $0 | 0 | SEC↗ |
| Drappa Jorn | Chief Medical Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 64,000 | — | $0 | 0 | SEC↗ |
| Drappa Jorn | Chief Medical Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 165,000 | — | $0 | 0 | SEC↗ |
| Chan Mitchell | Chief Financial Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 50,056 | — | $0 | 0 | SEC↗ |
| Chan Mitchell | Chief Financial Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 13,000 | — | $0 | 0 | SEC↗ |
| Chan Mitchell | Chief Financial Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 30,000 | — | $0 | 0 | SEC↗ |
| Chan Mitchell | Chief Financial Officer | D To issuer deriv | 2021-03-15 | 2021-03-15 | 67,500 | — | $0 | 0 | SEC↗ |
| Hu Edward | Director | D To issuer deriv | 2021-03-15 | 2021-03-15 | 7,358 | — | $0 | 0 | SEC↗ |
| Hu Edward | Director | D To issuer deriv | 2021-03-15 | 2021-03-15 | 26,210 | — | $0 | 0 | SEC↗ |
| AstraZeneca UK LTD | 10% Owner | U Tender | 2021-03-15 | 2021-03-16 | 14,650,334 | $53.00 | $776.47M | 0 | SEC↗ |
| Yao Zhengbin | Chief Executive Officer | D To issuer | 2021-03-13 | 2021-03-15 | 270,219 | $53.00 | $14.32M | 0 | SEC↗ |
| Yao Zhengbin | Chief Executive Officer | D To issuer | 2021-03-13 | 2021-03-15 | 200,000 | $53.00 | $10.60M | 0 | SEC↗ |
| Ragatz William | Senior VP, Head of Commercia | D To issuer | 2021-03-13 | 2021-03-15 | 16,250 | $53.00 | $861.3K | 0 | SEC↗ |
| Drappa Jorn | Chief Medical Officer | D To issuer | 2021-03-13 | 2021-03-15 | 202,661 | $53.00 | $10.74M | 0 | SEC↗ |
| Chan Mitchell | Chief Financial Officer | D To issuer | 2021-03-13 | 2021-03-15 | 37,500 | $53.00 | $1.99M | 0 | SEC↗ |
| Boyu Capital Fund III, L.P. | 10% Owner | U Tender | 2021-03-13 | 2021-03-15 | 300,000 | $53.00 | $15.90M | 0 | SEC↗ |
| Boyu Capital Fund III, L.P. | 10% Owner | U Tender | 2021-03-13 | 2021-03-15 | 8,322,353 | $53.00 | $441.08M | 0 | SEC↗ |
| Hu Edward | Director | D To issuer | 2021-03-13 | 2021-03-15 | 208,059 | $53.00 | $11.03M | 0 | SEC↗ |
| Hu Edward | Director | D To issuer | 2021-03-13 | 2021-03-15 | 3,953,118 | $53.00 | $209.52M | 0 | SEC↗ |
| Wicki Andreas | Director | D To issuer | 2021-03-13 | 2021-03-15 | 1,750,000 | $53.00 | $92.75M | 0 | SEC↗ |
| Cao Yanling | Director, 10% Owner | D To issuer | 2021-03-13 | 2021-03-16 | 8,322,353 | $53.00 | $441.08M | 0 | SEC↗ |
| Ren Aaron | See Remarks | M Exercise deriv | 2020-11-18 | 2020-11-18 | 2,000 | $2.84 | $5.7K | 82,789 | SEC↗ |
| Ren Aaron | See Remarks | M Exercise | 2020-11-18 | 2020-11-18 | 2,000 | $2.84 | $5.7K | 113,613 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 14,716 | — | $0 | 14,716 | SEC↗ |
| Hu Edward | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 7,358 | — | $0 | 7,358 | SEC↗ |
| Nolet Chris | Director | A Award deriv | 2020-06-19 | 2020-06-23 | 7,358 | — | $0 | 7,358 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2020-06-19 | 2020-06-24 | 14,716 | — | $0 | 14,716 | SEC↗ |
| Jacques Rachelle Suzanne | Director | A Award deriv | 2020-06-19 | 2020-06-24 | 7,358 | — | $0 | 7,358 | SEC↗ |
| Cao Yanling | Director, 10% Owner | S Sale | 2020-06-05 | 2020-06-08 | 360,000 | $47.00 | $16.92M | 8,322,353 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | S Sale | 2020-06-05 | 2020-06-08 | 360,000 | $47.00 | $16.92M | 8,622,353 | SEC↗ |
| Tong Xiaomeng | 10% Owner | S Sale | 2020-06-05 | 2020-06-08 | 360,000 | $47.00 | $16.92M | 8,622,353 | SEC↗ |
| Hu Edward | Director | S Sale | 2020-06-05 | 2020-06-09 | 171,000 | $44.18 | $7.55M | 3,953,118 | SEC↗ |
| Hu Edward | Director | S Sale | 2020-06-05 | 2020-06-09 | 9,000 | $44.18 | $397.6K | 208,059 | SEC↗ |
| Yao Zhengbin | Chief Executive Officer | A Award deriv | 2020-03-02 | 2020-03-04 | 188,057 | — | $0 | 188,057 | SEC↗ |
| Drappa Jorn | Chief Medical Officer | A Award deriv | 2020-03-02 | 2020-03-04 | 71,842 | — | $0 | 71,842 | SEC↗ |
| Chan Mitchell | Chief Financial Officer | A Award deriv | 2020-03-02 | 2020-03-04 | 50,056 | — | $0 | 50,056 | SEC↗ |
| Ren Aaron | VP, Head of Bus. Dev & Oper. | A Award deriv | 2020-03-02 | 2020-03-04 | 46,445 | — | $0 | 46,445 | SEC↗ |
| Ragatz William | VP, Head of Commercial | A Award deriv | 2020-03-02 | 2020-03-04 | 50,548 | — | $0 | 50,548 | SEC↗ |
| Ragatz William | VP, Head of Commercial | M Exercise deriv | 2020-01-27 | 2020-01-29 | 16,250 | — | $0 | 48,750 | SEC↗ |
| Ragatz William | VP, Head of Commercial | M Exercise | 2020-01-27 | 2020-01-29 | 16,250 | $5.22 | $84.8K | 16,250 | SEC↗ |
| Kastenmayer James Paul | General Counsel | A Award deriv | 2020-01-14 | 2020-01-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | P Buy | 2019-10-08 | 2019-10-10 | 36,091 | $21.83 | $787.9K | 36,091 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | P Buy | 2019-10-08 | 2019-10-25 | 36,091 | $21.83 | $787.9K | 300,000 | SEC↗ |
| Boyu Capital Investment Manage | 10% Owner | P Buy | 2019-10-08 | 2019-10-25 | 36,091 | $21.83 | $787.9K | 300,000 | SEC↗ |
| Hu Edward | Director | C Conversion deriv | 2019-10-07 | 2019-10-07 | 3,230,000 | — | $0 | 0 | SEC↗ |
| Hu Edward | Director | C Conversion deriv | 2019-10-07 | 2019-10-07 | 170,000 | — | $0 | 0 | SEC↗ |
| Hu Edward | Director | C Conversion deriv | 2019-10-07 | 2019-10-07 | 894,118 | — | $0 | 0 | SEC↗ |
| Hu Edward | Director | C Conversion deriv | 2019-10-07 | 2019-10-07 | 47,059 | — | $0 | 0 | SEC↗ |
| ASTRAZENECA PLC | 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-09 | 14,225,324 | — | $0 | 0 | SEC↗ |
| Wicki Andreas | Director | C Conversion deriv | 2019-10-07 | 2019-10-09 | 1,250,000 | — | $0 | 0 | SEC↗ |
| Boundless Meadow Ltd | 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-09 | 6,800,000 | — | $0 | 0 | SEC↗ |
| Boundless Meadow Ltd | 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-09 | 1,882,353 | — | $0 | 0 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-09 | 6,800,000 | — | $0 | 0 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-09 | 1,882,353 | — | $0 | 0 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-09 | 6,800,000 | — | $0 | 0 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-09 | 1,882,353 | — | $0 | 0 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-25 | 6,800,000 | — | $0 | 0 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-25 | 1,882,353 | — | $0 | 0 | SEC↗ |
| Boyu Capital Investment Manage | 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-25 | 6,800,000 | — | $0 | 0 | SEC↗ |
| Boyu Capital Investment Manage | 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-25 | 1,882,353 | — | $0 | 0 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-25 | 1,882,353 | — | $0 | 0 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion deriv | 2019-10-07 | 2019-10-25 | 6,800,000 | — | $0 | 0 | SEC↗ |
| Hu Edward | Director | C Conversion | 2019-10-07 | 2019-10-07 | 170,000 | — | $0 | 3,400,000 | SEC↗ |
| Hu Edward | Director | C Conversion | 2019-10-07 | 2019-10-07 | 894,118 | — | $0 | 4,294,118 | SEC↗ |
| Hu Edward | Director | C Conversion | 2019-10-07 | 2019-10-07 | 47,059 | — | $0 | 4,341,177 | SEC↗ |
| Hu Edward | Director | C Conversion | 2019-10-07 | 2019-10-07 | 3,230,000 | — | $0 | 3,230,000 | SEC↗ |
| ASTRAZENECA PLC | 10% Owner | C Conversion | 2019-10-07 | 2019-10-09 | 14,225,324 | — | $0 | 14,225,334 | SEC↗ |
| ASTRAZENECA PLC | 10% Owner | P Buy | 2019-10-07 | 2019-10-09 | 425,000 | $19.00 | $8.07M | 14,650,334 | SEC↗ |
| Wicki Andreas | Director | P Buy | 2019-10-07 | 2019-10-09 | 500,000 | $19.00 | $9.50M | 1,750,000 | SEC↗ |
| Wicki Andreas | Director | C Conversion | 2019-10-07 | 2019-10-09 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| Boundless Meadow Ltd | 10% Owner | C Conversion | 2019-10-07 | 2019-10-09 | 6,800,000 | — | $0 | 6,800,000 | SEC↗ |
| Boundless Meadow Ltd | 10% Owner | C Conversion | 2019-10-07 | 2019-10-09 | 1,882,353 | — | $0 | 1,882,353 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-09 | 1,882,353 | — | $0 | 1,882,353 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-09 | 6,800,000 | — | $0 | 6,800,000 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | P Buy | 2019-10-07 | 2019-10-09 | 300,000 | $19.00 | $5.70M | 300,000 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-09 | 1,882,353 | — | $0 | 1,882,353 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-09 | 6,800,000 | — | $0 | 6,800,000 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | S Sale | 2019-10-07 | 2019-10-10 | 36,091 | $22.18 | $800.5K | 36,091 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | P Buy | 2019-10-07 | 2019-10-25 | 300,000 | $19.00 | $5.70M | 300,000 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-25 | 1,882,353 | — | $0 | 8,682,353 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-25 | 6,800,000 | — | $0 | 6,800,000 | SEC↗ |
| Tong Xiaomeng | Director, 10% Owner | S Sale | 2019-10-07 | 2019-10-25 | 36,091 | $22.18 | $800.5K | 263,909 | SEC↗ |
| Boyu Capital Investment Manage | 10% Owner | C Conversion | 2019-10-07 | 2019-10-25 | 6,800,000 | — | $0 | 6,800,000 | SEC↗ |
| Boyu Capital Investment Manage | 10% Owner | P Buy | 2019-10-07 | 2019-10-25 | 300,000 | $19.00 | $5.70M | 300,000 | SEC↗ |
| Boyu Capital Investment Manage | 10% Owner | S Sale | 2019-10-07 | 2019-10-25 | 36,091 | $22.18 | $800.5K | 263,909 | SEC↗ |
| Boyu Capital Investment Manage | 10% Owner | C Conversion | 2019-10-07 | 2019-10-25 | 1,882,353 | — | $0 | 8,682,353 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-25 | 6,800,000 | — | $0 | 6,800,000 | SEC↗ |
| Cao Yanling | Director, 10% Owner | C Conversion | 2019-10-07 | 2019-10-25 | 1,882,353 | — | $0 | 8,682,353 | SEC↗ |
| Hu Edward | Director | A Award deriv | 2019-10-02 | 2019-10-02 | 26,210 | — | $0 | 26,210 | SEC↗ |
| Nolet Chris | Director | A Award deriv | 2019-10-02 | 2019-10-02 | 26,210 | — | $0 | 26,210 | SEC↗ |